Phase II Trial, NIS793E12201, An Open-Label, Three-Arm Phase II Study Of NIS793 With Or Without Spartalizumab In Combination With Standard Of Care Anti-Cancer Therapy For The Second Line Treatment Of Metastatic Colorectal Cancer

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04952753

Study #:
STUDY00149075

Start Date:
Jan 10, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04952753

View Complete Trial Details & Eligibility at ClinicalTrials.gov